Literature DB >> 24803013

The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models.

Mònica Aguilera1, Trevor Darby2, Silvia Melgar3.   

Abstract

Inflammasomes are a large family of multiprotein complexes recognizing pathogen-associated molecular pattern molecules (PAMPs) and damage-associated molecular patterns (DAMPs). This leads to caspase-1 activation, promoting the secretion of mature IL-1β, IL-18 and under certain conditions even induce pyroptosis. Inflammatory Bowel Diseases (IBD) is associated with alterations in microbiota composition, inappropriate immune responses and genetic predisposition associated to bacterial sensing and autophagy. Besides their acknowledged role in mounting microbial induced host responses, a crucial role in maintenance of intestinal homeostasis was revealed in inflammasome deficient mice. Further, abnormal activation of these functions appears to contribute to the pathology of intestinal inflammation including IBD and colitis-associated cancer. Herein, the current literature implicating the inflammasomes, microbiota and IBD is comprehensively reviewed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caspase-1; Colitis-associated cancer; IBD; Inflammasomes; Microbiota

Mesh:

Substances:

Year:  2014        PMID: 24803013     DOI: 10.1016/j.cytogfr.2014.04.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  22 in total

1.  Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.

Authors:  Lazaros-Dimitrios Lazaridis; Aikaterini Pistiki; Evangelos J Giamarellos-Bourboulis; Marianna Georgitsi; Georgia Damoraki; Dimitrios Polymeros; George D Dimitriadis; Konstantinos Triantafyllou
Journal:  Dig Dis Sci       Date:  2017-05-18       Impact factor: 3.199

2.  Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.

Authors:  Kirk Bergstrom; Xiaowei Liu; Yiming Zhao; Nan Gao; Qian Wu; Kai Song; Yi Cui; Yun Li; J Michael McDaniel; Samuel McGee; Weichang Chen; Mark M Huycke; Courtney W Houchen; Lauren A Zenewicz; Christopher M West; Hong Chen; Jonathan Braun; Jianxin Fu; Lijun Xia
Journal:  Gastroenterology       Date:  2016-04-06       Impact factor: 22.682

Review 3.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

4.  Altered expression of inflammasomes in Hirschsprung's disease.

Authors:  Hiroki Nakamura; Anne Marie O'Donnell; Naoum Fares Marayati; Christian Tomuschat; David Coyle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2018-11-01       Impact factor: 1.827

Review 5.  Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.

Authors:  Fillipe M de Araújo; Lorena Cuenca-Bermejo; Emiliano Fernández-Villalba; Silvia L Costa; Victor Diogenes A Silva; Maria Trinidad Herrero
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

Review 6.  Immune Homeostasis in Epithelial Cells: Evidence and Role of Inflammasome Signaling Reviewed.

Authors:  Paul M Peeters; Emiel F Wouters; Niki L Reynaert
Journal:  J Immunol Res       Date:  2015-08-19       Impact factor: 4.818

7.  Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.

Authors:  Steffen Bank; Paal Skytt Andersen; Johan Burisch; Natalia Pedersen; Stine Roug; Julied Galsgaard; Stine Ydegaard Turino; Jacob Broder Brodersen; Shaista Rashid; Britt Kaiser Rasmussen; Sara Avlund; Thomas Bastholm Olesen; Hans Jürgen Hoffmann; Bjørn Andersen Nexø; Jacob Sode; Ulla Vogel; Vibeke Andersen
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

Review 8.  Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives.

Authors:  Ema Ozaki; Matthew Campbell; Sarah L Doyle
Journal:  J Inflamm Res       Date:  2015-01-16

9.  Molecular basis of caspase-1 polymerization and its inhibition by a new capping mechanism.

Authors:  Alvin Lu; Yang Li; Florian I Schmidt; Qian Yin; Shuobing Chen; Tian-Min Fu; Alexander B Tong; Hidde L Ploegh; Youdong Mao; Hao Wu
Journal:  Nat Struct Mol Biol       Date:  2016-04-04       Impact factor: 15.369

10.  The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway.

Authors:  Rojo A Ratsimandresy; Mohanalaxmi Indramohan; Andrea Dorfleutner; Christian Stehlik
Journal:  Cell Mol Immunol       Date:  2016-08-15       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.